Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ann L. Quill"'
Autor:
Gilles Montalescot, Ann L. Quill, Allison Wyman, Joel M. Gore, Alvaro Alonso, Frans Van de Werf, Keith A.A. Fox, Ph. Gabriel Steg, Christopher B. Granger, Hamza H. Awad, Dietrich C. Gulba, Kim A. Eagle
Publikováno v:
European Heart Journal: Acute Cardiovascular Care. 2:280-291
To describe the characteristics, treatment, and mortality in patients with ST-elevation myocardial infarction (STEMI) by use of chronic oral anticoagulant (OAC) therapy.Using data from the Global Registry of Acute Coronary Syndromes (GRACE), patient
Autor:
Ann L. Quill, Thomas K. Houston, Stephanie L. Shimada, Sowmya R. Rao, Timothy P. Hogan, Barrett D. Phillips, Kim M. Nazi, Susan T. Haidary, Jeroan J. Allison, Hua Feng
Publikováno v:
Medical Care. 51:S21-S28
The Veterans Health Administration has implemented patient to clinical team electronic asynchronous secure messaging (SM). This disruptive technology has the potential to support continuous, coordinated quality care, but limited evidence supports thi
Autor:
Keith A.A. Fox, P. Gabriel Steg, Shaun G. Goodman, Grace Investigators, David Brieger, Andrew T. Yan, Ann L. Quill, Heather Shenkman, Sanjit S. Jolly, Kim A. Eagle, Ki-Dong Lim
Publikováno v:
Heart. 97:197-202
The objective of this study was to determine if the extent of quantitative troponin elevation predicted mortality as well as in-hospital complications of cardiac arrest, new heart failure and cardiogenic shock.16,318 patients with non-ST-segment elev
Autor:
Shaun G. Goodman, Ann L. Quill, Jose Lopez-Sendon, Gilles Montalescot, Hitinder S. Gurm, Troy M. LaBounty, Kim A. Eagle
Publikováno v:
The American Journal of Medicine. 122:144-151
Q-waves in ST-elevation acute coronary syndromes carry adverse implications. We sought to determine the frequency, predictors, and implications of Q-waves in the current era that includes primary percutaneous coronary interventions.There were 14,916
Autor:
Kim A. Eagle, Frans Van de Werf, Keith A.A. Fox, Shaun G. Goodman, Phillippe Gabriel Steg, Rajendra H. Mehta, Jose Lopez-Sendon, Ann L. Quill, Christopher B. Granger, Brahmajee K. Nallamothu
Publikováno v:
European Heart Journal. 29:609-617
Many patients who are eligible for acute reperfusion therapy receive it after substantial delays or not at all. We wanted to determine whether over the years more patients are receiving reperfusion therapy.This analysis is based on 10 954 patients wi
Autor:
Allen L. Gifford, Sowmya R. Rao, D. Keith McInnes, Kirsha S. Gordon, Amy C. Justice, Stephanie L. Shimada, Thomas K. Houston, Ann L. Quill, Mona Duggal, Michael E. Ohl, Lewis E. Kazis, Kristin M. Mattocks, Cynthia Brandt
Publikováno v:
AIDS and behavior. 17(9)
Patient electronic personal health record (PHR) use has been associated with improved patient outcomes in diabetes and depression care. Little is known about the effect of PHR use on HIV care processes and outcomes. We evaluated whether there was an
Autor:
Ann L. Quill, Hoa L. Nguyen, Kim A. Eagle, Joel M. Gore, Keith A.A. Fox, Frederick A. Anderson, Robert J. Goldberg, George W. Reed, Enrique P. Gurfinkel, Frederick A. Spencer
Publikováno v:
Coronary artery disease. 21(6)
BACKGROUND: A limited number of studies have examined the age and sex differences, and potentially changing trends, in cardiac medication and procedure use in patients hospitalized with an acute coronary syndrome (ACS). METHODS: Using data from a lar
Autor:
James B. Froehlich, Gilles Montalescot, Joel M. Gore, Ann L. Quill, Hitinder S. Gurm, David Brieger, Kim A. Eagle, Ameeth Vedre, Eva Kline-Rogers
Publikováno v:
The American journal of cardiology. 104(12)
Animal models of myocardial ischemia have demonstrated reduction in arrhythmias using statins. It was hypothesized that previous statin therapy before hospitalization might be associated with reductions of in-hospital arrhythmic events in patients wi
Autor:
Ann L. Quill, Shaun G. Goodman, Frederick A. Anderson, Grace Investigators, Karen S. Pieper, Joel M. Gore, P. Gabriel Steg, Keith A.A. Fox
Publikováno v:
Nature clinical practice. Cardiovascular medicine. 5(9)
The time course of events after acute coronary syndromes might influence the timing and duration of therapeutic interventions. We investigated the impact of risk status and ST-segment category at presentation.The timing of death, reinfarction, stroke
Autor:
Marcus Flather, Shaun G. Goodman, Andrzej Budaj, Grace Investigators, Frederick A. Anderson, Keith A.A. Fox, Christopher B. Granger, Joel M. Gore, Kim A. Eagle, Ann L. Quill, Philippe Gabriel Steg
Publikováno v:
JAMA. 297(17)
Context Randomized trials provide robust evidence for the impact of pharmacological and interventional treatments in patients with ST-segment elevation and non–STsegment elevation acute coronary syndromes (NSTE ACS), but whether this translates to